RABIES VACCINE INACTIVATED DRIED POWDER FOR SOLUTION Canadà - anglès - Health Canada

rabies vaccine inactivated dried powder for solution

aventis pasteur limited - rabies vaccine inactivated (human diploid-cell culture) - powder for solution - 2.5unit - rabies vaccine inactivated (human diploid-cell culture) 2.5unit - vaccines

Rabies vaccine powder for suspension for injection 1ml vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

rabies vaccine powder for suspension for injection 1ml vials

a a h pharmaceuticals ltd - rabies virus inactivated - powder and solvent for suspension for injection

Rabies vaccine powder and solvent for suspension for injection 1ml vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

rabies vaccine powder and solvent for suspension for injection 1ml vials

alliance healthcare (distribution) ltd - rabies virus inactivated - powder and solvent for suspension for injection

Rabisin Irlanda - anglès - HPRA (Health Products Regulatory Authority)

rabisin

boehringer ingelheim vetmedica gmbh - rabies virus glycoprotein - suspension for injection - . - rabies virus

Purevax Rabies (See reverse for formulation) Suspension for Injection (SC) Filipines - anglès - FDA (Food And Drug Administration)

purevax rabies (see reverse for formulation) suspension for injection (sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live recombinant rabies virus vaccine (vet.) - suspension for injection (sc) - (see reverse for formulation)

Verorab Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

verorab

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) - powder for injection with diluent - 3.25 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) excipient: albumin hydrochloric acid bme medium - mineral salts, vitamins, amino acids including l-phenylalanine maltose sodium hydroxide sodium chloride water for injection - verorab is indicated for pre-exposure prophylaxis against rabies. verorab is indicated for post-exposure prophylaxis against rabies. verorab should be used in accordance with official local recommendations.

VERORAB Israel - anglès - Ministry of Health

verorab

sanofi israel ltd - rabies, inactivated, whole virus - powder and solvent for suspension for injection - rabies, inactivated, whole virus 2.5 iu - rabies, inactivated, whole virus - rabies, inactivated, whole virus - prevention of rabies in children and adults. it can be used before and after exposure, as a primary vaccination or as a booster dose.

RABAVERT- rabies vaccine kit Estats Units - anglès - NLM (National Library of Medicine)

rabavert- rabies vaccine kit

a-s medication solutions - rabies virus strain flury lep antigen (propiolactone inactivated) (unii: fk894q51ye) (rabies virus strain flury lep antigen (propiolactone inactivated) - unii:fk894q51ye) - rabavert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. usually an immunization series is initiated and completed with 1 vaccine product. no clinical studies have been conducted that document a change in efficacy or the frequency of adverse reactions when the series is completed with a second vaccine product. however, for booster immunization, rabavert was shown to elicit protective antibody level responses in persons tested who received a primary series with hdcv.4,11 preexposure vaccination: see table 1 and dosage and administration. preexposure vaccination consists of 3 doses of rabavert 1.0 ml given intramuscularly (deltoid region), 1 each on days 0, 7, and 21 or 281 (see also table 1 for criteria for preexposure vaccination). preexposure vaccination does not eliminate the need for additional therapy after a known rabies exposure (see dosage and administration: postexposure prophylaxis of previously im